Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | MMP12 | P39900 | 1/20 | 0.40 |
| ▸ | MMP14 | P50281 | 1/20 | 0.40 |
| ▸ | MMP15 | P51511 | 1/20 | 0.40 |
| ▸ | MMP16 | P51512 | 1/20 | 0.40 |
| ▸ | MMP26 | Q9NRE1 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.40 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.40 |
| ▸ | ACACB | O00763 | 8/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6865278 | 0.90 | MMP2 (0.43) | TSHRL3MBTL1MMP2MMP9MMP12 | |
| SCHEMBL6867004 | 0.89 | MMP2 (0.41) | TSHRMMP2MMP9MMP12MMP14 | |
| SCHEMBL6865607 | 0.88 | TSHR (0.41) | TSHRL3MBTL1CA12CA1CA2 | |
| SCHEMBL6388169 | 0.84 | CA12 (0.59) | TSHRL3MBTL1CA12CA1CA2 | |
| SCHEMBL6388164 | 0.84 | CA12 (0.59) | TSHRL3MBTL1CA12CA1CA2 | |
| SCHEMBL6858922 | 0.83 | CA12 (0.41) | TSHRL3MBTL1CA12CA1CA2 | |
| SCHEMBL6549016 | 0.82 | MAPT (0.47) | TSHRL3MBTL1CA12CA1CA2 | |
| SCHEMBL6394341 | 0.81 | CA12 (0.54) | TSHRCA12CA1CA2CA7 | |
| SCHEMBL6393368 | 0.79 | TSHR (0.44) | TSHRL3MBTL1CA12CA1CA2 | |
| SCHEMBL6393362 | 0.79 | TSHR (0.44) | TSHRL3MBTL1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6805921-B2 | Liquid crystal display | MITSUBISHI GAS CHEMICAL CO., INC. (JP) | 2004-10-19 | — | — | US | disclosed |
| US-20030102459-A1 | Optically active compound and nematic liquid crystal composition containing the compound | MITSUBISHI GAS CHEMICAL CO., INC. | 2003-06-05 | — | — | US | disclosed |
| EP-1283253-A1 | Optically active compound and nematic liquid crystal composition containing the compound | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2003-02-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030102459-A1 | Optically active compound and nematic liquid crystal composition containing the compound | NCAPH, H1-0, CNOT1 | TSHR 4320/4885L3MBTL1 605/4885MMP2 4630/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.